Literature DB >> 2460698

Quantitation of a murine lung endothelial cell protein, P112, with a double monoclonal antibody assay.

S J Kennel1, T Lankford, B Hughes, J A Hotchkiss.   

Abstract

Two monoclonal antibodies (MoAb) have been isolated from two different F344 rats immunized with normal BALB/c mouse lung homogenates. The MoAbs 273-34A and 411-201B demonstrate similar staining properties when used in immunohistochemistry and have been shown to bind to endothelial cells in the lung using immunogold electron microscopy. Radiolabeled MoAb 273-34A injected intravenously localizes rapidly to lung. Ratios of MoAb to control and values for percentage of recovered dose/gram are 50-fold higher in lung than in other organs. Both MoAbs recognize the same 112 kilodalton protein (P112) on the surface of lung cells in culture but do not compete for binding with each other. Both antibodies can be used to purify P112 from normal mouse lung homogenate using immunoaffinity chromatography. These MoAb have been used in a two-site, quantitative assay for P112. Data show that normal lung contains high amounts of P112 (500 to 700 ng/mg P), whereas other organs have low (spleen, uterus) or undetectable (liver) levels of P112. We conclude that endothelial cells in different organs are not identical and that P112 is preferentially expressed in lung endothelial cells. Quantitation of P112 may be useful to assess the role of endothelial cells in toxic injury, lung diseases, and growth and vascularization of lung tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460698

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  12 in total

1.  Factors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.

Authors:  Vladimir V Shuvaev; Melpo Christofidou-Solomidou; Arnaud Scherpereel; Eric Simone; Evguenia Arguiri; Samira Tliba; Jeremy Pick; Stephen Kennel; Steven M Albelda; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2007-01-08       Impact factor: 9.776

2.  A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.

Authors:  H Weiler-Guettler; P D Christie; D L Beeler; A M Healy; W W Hancock; H Rayburn; J M Edelberg; R D Rosenberg
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

3.  Long-circulating immunoliposomal amphotericin B against invasive pulmonary aspergillosis in mice.

Authors:  T Otsubo; K Maruyama; S Maesaki; Y Miyazaki; E Tanaka; T Takizawa; K Moribe; K Tomono; T Tashiro; S Kohno
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

4.  Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity.

Authors:  Y Zhang; H Weiler-Guettler; J Chen; O Wilhelm; Y Deng; F Qiu; K Nakagawa; M Klevesath; S Wilhelm; H Böhrer; M Nakagawa; H Graeff; E Martin; D M Stern; R D Rosenberg; R Ziegler; P P Nawroth
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

5.  Thrombomodulin distribution during murine development.

Authors:  Virginia A Ford; John E Wilkinson; Stephen J Kennel
Journal:  Rouxs Arch Dev Biol       Date:  1993-08

6.  Absence of the blood-clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system.

Authors:  A M Healy; H B Rayburn; R D Rosenberg; H Weiler
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

7.  Endothelial targeting of polymeric nanoparticles stably labeled with the PET imaging radioisotope iodine-124.

Authors:  Eric A Simone; Blaine J Zern; Ann-Marie Chacko; John L Mikitsh; Eric R Blankemeyer; Silvia Muro; Radu V Stan; Vladimir R Muzykantov
Journal:  Biomaterials       Date:  2012-05-04       Impact factor: 12.479

8.  Lipid composition is important for highly efficient target binding and retention of immunoliposomes.

Authors:  K Maruyama; S J Kennel; L Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

9.  Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.

Authors:  A Mori; S J Kennel; M van Borssum Waalkes; G L Scherphof; L Huang
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

10.  Pharmacological targeting of the thrombomodulin-activated protein C pathway mitigates radiation toxicity.

Authors:  Hartmut Geiger; Snehalata A Pawar; Edward J Kerschen; Kalpana J Nattamai; Irene Hernandez; Hai Po H Liang; Jose Á Fernández; Jose A Cancelas; Marnie A Ryan; Olga Kustikova; Axel Schambach; Qiang Fu; Junru Wang; Louis M Fink; Karl-Uwe Petersen; Daohong Zhou; John H Griffin; Christopher Baum; Hartmut Weiler; Martin Hauer-Jensen
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.